“…We have been involved in research on the synthesis and biological evaluation of a series of polycyclic N ‐heterocyclic compounds. During our investigation of the antidepressive activity and antiplatelet aggregation activity of these compounds, we discovered that 4‐alkylamino‐5,6‐dihydrobenzo[ h ]quinazolines ( 1 ) and 4‐alkylamino‐6,7‐dihydro‐5 H ‐pyrimido[5,4‐ d ][1]benzazepines ( 2 ) had stronger inhibitory activities against collagen‐induced aggregation of rabbit platelets in vitro than aspirin, the well‐known antiplatelet agent (Figure ) . The most potent 1 (R 1 = H and R 2 = Et) had nine times the activity of aspirin, whereas the most potent 2 (NR 1 R 2 = morpholino) had 14 times the activity of aspirin.…”